EYLEA

  Рет қаралды 43,049

Tarek Youssef

Tarek Youssef

Күн бұрын

ted for the treatment of patients with neovascular (Wet) Age-related Macular Degeneration (AMD). Indicated for the treatment of patients with Macular Edema following Central Retinal Vein Occlusion (CRVO). EYLEA is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.

Пікірлер: 20
Increased dose of Eylea to extend treatment intervals
59:49
Macular Society
Рет қаралды 3,3 М.
New treatments for wet AMD, Nigel Davies
23:14
Macular Society
Рет қаралды 35 М.
This mother's baby is too unreliable.
00:13
FUNNY XIAOTING 666
Рет қаралды 25 МЛН
Which One Is The Best - From Small To Giant #katebrush #shorts
00:17
OCT in diabetic Retinopathy || OCT patterns of DME || Biomarkers in OCT
22:12
Insight Ophthalmology
Рет қаралды 22 М.
Avastin vs Eylea in Exudative AMD: More than Anecdotal Evidence
18:57
IRMA vs NVE || intraretinal microvascular abnormality vs neovascularisation
13:31
Exploring New Insights into Wet AMD | VEGF Trap-Eye: A Novel Molecule Under Investigation
6:08
Zoomedia Inc. - Communications for the Life Sciences
Рет қаралды 10 М.
Mastering OCT Interpretation with Dr. Mark Friedberg
2:00:08
ODwire.org
Рет қаралды 349 М.
Anti-VEGF Eye Injections - Why ? For which patients ? Cost ? Risks ? | Dr. Shrutika Kankariya
14:03
Asian Eye Hospital Pune No.1 LASIK Center in India
Рет қаралды 111 М.